Loading...
U.S. imports of concentrates of poppy straw, buprenorphine, and specified opium alkaloids (HS 293911) totaled $12.6M in July 2026, traded with 9 countries.
Concentrates of Poppy Straw, Buprenorphine, and Specified Opium Alkaloids imports of $12.6M in July 2026 ran 42% above the year-to-date monthly average of $8.9M.
Last updated: July 2026 dataPoppy straw concentrates and buprenorphine — a Schedule III opioid widely used in medication-assisted treatment for opioid use disorder — are the primary commercial articles under this heading, and all imports require both DEA Schedule I/II/III import authorization and FDA admissibility review. Australia and the United Kingdom are the leading US suppliers, reflecting their status as major licensed producers of licit opiate raw materials under the International Narcotics Control Board framework. The tight international quota system governing licit opium alkaloid production means supply availability is constrained by annual INCB estimates, making long-term supply agreements with licensed foreign manufacturers a standard industry practice.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
17 shipments/mo
Importers must hold a DEA Schedule I or II importer registration (depending on the specific substance) and obtain an import permit for each shipment. The DEA evaluates permit applications against US aggregate production quotas and INCB estimates. FDA registration of the foreign manufacturing site and a valid Drug Master File are also required. Delays in permit issuance can disrupt pharmaceutical manufacturing schedules, so importers typically apply well in advance of planned shipment dates. Consult a licensed customs broker and DEA-registered counsel for current procedural requirements.
The International Narcotics Control Board sets annual global estimates for licit opiate raw material production, and each producing country — including Australia and the UK — operates within those limits. When global demand for opioid APIs rises or a major crop is affected by weather, the quota ceiling can constrain supply even from well-established licensed producers. US pharmaceutical manufacturers typically monitor INCB estimate revisions and coordinate with DEA on domestic quota allocations to anticipate potential shortfalls.
HSChapter 29
Subheading 2 of 18 in heading 2939
Subheading 293911 · $12.6M of $55.3M
Supplier Network
Get discovered by U.S. importers searching for HS 293911 — Concentrates of Poppy Straw, Buprenorphine, and Specified Opium Alkaloids. Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Dutiable Share | Duty Collected |
|---|---|---|---|---|---|
| 2939110000 | Concentrates of Poppy Straw, Buprenorphne (Inn) | $12.6M | 0.03% | 0.31% | $4K |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 2939110000 | Concentrates of Poppy Straw, Buprenorphne (Inn) | $572K |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
ImportsExports
Imports
$12.6MYoY · Pro
Exports
$572KYoY · Pro
12-mo low · imports
YoY · ProThrough July 2026. Source: U.S. Census Bureau.
Imports · July 2026
origin
Australia and United Kingdom together supply 55% of it.
customs district
destination
entry
rate provision · imports
99.7% enters free of duty; the effective duty rate is 0.03%.